Cronkhite-Canada Syndrome

Report of Two Cases, Biopsy Findings in the Associated Alopecia, and a New Treatment Option

Jill Allbritton, Eva Simmons-O'Brien, David Hutcheons, S. Elizabeth Whitmore

Research output: Contribution to journalArticle

Abstract

Two patients with Cronkhite-Canada syndrome (CCS) are reported, both of whom had diffuse alopecia, nail and skin changes, gastrointestinal polyposis, diarrhea, and wasting. A scalp biopsy was performed in one patient, and the specimen showed a marked noninflammatory loss of follicular units, miniaturization of the hair shafts, markedly dilated follicles, and a heavy deposition of glycosaminoglycans in the reticular dermis. This patient responded to prednisone therapy. The other patient was found to have elevated gastric acid levels and responded to ranitidine therapy. The conditions of both patients are now in remission two and six years later, respectively. Our patients have shown a temporally related remission of disease during treatment with prednisone and ranitidine, suggesting that each agent may be effective in CCS. However, randomized placebo-controlled trials are needed to prove the efficacy of these therapies. Further investigation of the histopathologic features of the associated alopecia may determine its cause.

Original languageEnglish (US)
Pages (from-to)229-232
Number of pages4
JournalCutis
Volume61
Issue number4
StatePublished - 1998

Fingerprint

Intestinal Polyposis
Alopecia
Biopsy
Ranitidine
Prednisone
Therapeutics
Miniaturization
Gastric Acid
Dermis
Nails
Glycosaminoglycans
Scalp
Hair
Diarrhea
Randomized Controlled Trials
Placebos
Skin

ASJC Scopus subject areas

  • Dermatology
  • Immunology and Allergy

Cite this

Allbritton, J., Simmons-O'Brien, E., Hutcheons, D., & Elizabeth Whitmore, S. (1998). Cronkhite-Canada Syndrome: Report of Two Cases, Biopsy Findings in the Associated Alopecia, and a New Treatment Option. Cutis, 61(4), 229-232.

Cronkhite-Canada Syndrome : Report of Two Cases, Biopsy Findings in the Associated Alopecia, and a New Treatment Option. / Allbritton, Jill; Simmons-O'Brien, Eva; Hutcheons, David; Elizabeth Whitmore, S.

In: Cutis, Vol. 61, No. 4, 1998, p. 229-232.

Research output: Contribution to journalArticle

Allbritton, J, Simmons-O'Brien, E, Hutcheons, D & Elizabeth Whitmore, S 1998, 'Cronkhite-Canada Syndrome: Report of Two Cases, Biopsy Findings in the Associated Alopecia, and a New Treatment Option', Cutis, vol. 61, no. 4, pp. 229-232.
Allbritton J, Simmons-O'Brien E, Hutcheons D, Elizabeth Whitmore S. Cronkhite-Canada Syndrome: Report of Two Cases, Biopsy Findings in the Associated Alopecia, and a New Treatment Option. Cutis. 1998;61(4):229-232.
Allbritton, Jill ; Simmons-O'Brien, Eva ; Hutcheons, David ; Elizabeth Whitmore, S. / Cronkhite-Canada Syndrome : Report of Two Cases, Biopsy Findings in the Associated Alopecia, and a New Treatment Option. In: Cutis. 1998 ; Vol. 61, No. 4. pp. 229-232.
@article{b47d33a2338a44d3acf5fe509689787f,
title = "Cronkhite-Canada Syndrome: Report of Two Cases, Biopsy Findings in the Associated Alopecia, and a New Treatment Option",
abstract = "Two patients with Cronkhite-Canada syndrome (CCS) are reported, both of whom had diffuse alopecia, nail and skin changes, gastrointestinal polyposis, diarrhea, and wasting. A scalp biopsy was performed in one patient, and the specimen showed a marked noninflammatory loss of follicular units, miniaturization of the hair shafts, markedly dilated follicles, and a heavy deposition of glycosaminoglycans in the reticular dermis. This patient responded to prednisone therapy. The other patient was found to have elevated gastric acid levels and responded to ranitidine therapy. The conditions of both patients are now in remission two and six years later, respectively. Our patients have shown a temporally related remission of disease during treatment with prednisone and ranitidine, suggesting that each agent may be effective in CCS. However, randomized placebo-controlled trials are needed to prove the efficacy of these therapies. Further investigation of the histopathologic features of the associated alopecia may determine its cause.",
author = "Jill Allbritton and Eva Simmons-O'Brien and David Hutcheons and {Elizabeth Whitmore}, S.",
year = "1998",
language = "English (US)",
volume = "61",
pages = "229--232",
journal = "Cutis",
issn = "0011-4162",
publisher = "Quadrant Healthcom Inc.",
number = "4",

}

TY - JOUR

T1 - Cronkhite-Canada Syndrome

T2 - Report of Two Cases, Biopsy Findings in the Associated Alopecia, and a New Treatment Option

AU - Allbritton, Jill

AU - Simmons-O'Brien, Eva

AU - Hutcheons, David

AU - Elizabeth Whitmore, S.

PY - 1998

Y1 - 1998

N2 - Two patients with Cronkhite-Canada syndrome (CCS) are reported, both of whom had diffuse alopecia, nail and skin changes, gastrointestinal polyposis, diarrhea, and wasting. A scalp biopsy was performed in one patient, and the specimen showed a marked noninflammatory loss of follicular units, miniaturization of the hair shafts, markedly dilated follicles, and a heavy deposition of glycosaminoglycans in the reticular dermis. This patient responded to prednisone therapy. The other patient was found to have elevated gastric acid levels and responded to ranitidine therapy. The conditions of both patients are now in remission two and six years later, respectively. Our patients have shown a temporally related remission of disease during treatment with prednisone and ranitidine, suggesting that each agent may be effective in CCS. However, randomized placebo-controlled trials are needed to prove the efficacy of these therapies. Further investigation of the histopathologic features of the associated alopecia may determine its cause.

AB - Two patients with Cronkhite-Canada syndrome (CCS) are reported, both of whom had diffuse alopecia, nail and skin changes, gastrointestinal polyposis, diarrhea, and wasting. A scalp biopsy was performed in one patient, and the specimen showed a marked noninflammatory loss of follicular units, miniaturization of the hair shafts, markedly dilated follicles, and a heavy deposition of glycosaminoglycans in the reticular dermis. This patient responded to prednisone therapy. The other patient was found to have elevated gastric acid levels and responded to ranitidine therapy. The conditions of both patients are now in remission two and six years later, respectively. Our patients have shown a temporally related remission of disease during treatment with prednisone and ranitidine, suggesting that each agent may be effective in CCS. However, randomized placebo-controlled trials are needed to prove the efficacy of these therapies. Further investigation of the histopathologic features of the associated alopecia may determine its cause.

UR - http://www.scopus.com/inward/record.url?scp=0032042391&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032042391&partnerID=8YFLogxK

M3 - Article

VL - 61

SP - 229

EP - 232

JO - Cutis

JF - Cutis

SN - 0011-4162

IS - 4

ER -